Actinium Pharmaceuticals
ATNM
#9653
Rank
C$57.2 M
Marketcap
$1.83
Share price
-7.19%
Change (1 day)
-85.17%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -C$60.75 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are C$0.08 Million. In 2023 the company made an earning of -C$73.81 Million a decrease over its 2022 earnings that were of -C$48.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$60.75 Million-17.71%
2023 -C$73.81 Million52.24%
2022 -C$48.49 Million36.61%
2021 -C$35.49 Million11.48%
2020 -C$31.84 Million1.46%
2019 -C$31.38 Million-7.37%
2018 -C$33.88 Million-11.46%
2017 -C$38.26 Million10.67%
2016 -C$34.57 Million15.7%
2015 -C$29.88 Million-14.86%
2014 -C$35.1 Million129.19%
2013 -C$15.32 Million-8.55%
2012 -C$16.75 Million
2010 C$0.01 M-152.15%
2009 -C$0.03 Million-39.8%
2008 -C$0.04 Million120.29%
2007 -C$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$52.88 Million-17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.77 B-1,305.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$40.88 Million-36.04%๐Ÿ‡บ๐Ÿ‡ธ USA